Jost Fischer insider trades
Open-market stock purchases and sales by Jost Fischer, Director at AEON Biopharma, Inc, from SEC Form 4 filings since Nov 30, 2010.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -53%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | AEON AEON Biopharma, Inc | Bought (not open market) | — |